5-Amino-1MQ NNMT inhibitor NAD salvage pathway methylation small molecule research compound Durham Peptides Canada 5-Amino-1MQ occupies an unusual corner of the Durham Peptides catalog — it's not a peptide. It's a small-molecule research compound, specifically a selective inhibitor of an enzyme called NNMT (nicotinamide N-methyltransferase). The reason it appears alongside the peptide catalog is its mechanistic overlap with NAD+ research: by inhibiting NNMT, 5-Amino-1MQ has b

Selank vs Semax tuftsin ACTH analog Russian neuropeptide comparison Durham Peptides Canada Selank and Semax are the two most-studied Russian-developed neuropeptides in current research, and they appear together so often in cognitive-research discussions that they're easy to conflate. They share several superficial properties — both seven amino acids, both developed at the same Russian research institutes, both with stabilizing modifications, both studied for central nervous s

Selank tuftsin analog anxiolytic nootropic BDNF Russian research peptide Durham Peptides Canada Selank is one of the more distinctive compounds in the broader nootropic research peptide category — a synthetic peptide derived from tuftsin, a naturally-occurring immunopeptide found in the body. Its research story sits at a genuinely unusual intersection: neuropeptide pharmacology, anxiolytic research, and immunopeptide biology, all in one short sequence. Like Semax, it was deve

Peptide research 2026 year in review FDA PCAC CagriSema regulatory clinical developments Durham Peptides Canada 2026 has been one of the most consequential years in peptide research in recent memory — major regulatory shifts at the FDA, headline clinical readouts from advanced metabolic-peptide trials, and continued category development across both established and emerging compounds. This article is a research-focused year-in-review of what actually happened, with every claim

Peptide research ethics reproducibility data integrity research compound integrity Durham Peptides Canada Research ethics is a topic that sounds abstract until you realize how directly it shapes the quality of the research you produce. Reproducibility, honest reporting, conflict-of-interest disclosure, and proper handling of research compounds are not bureaucratic checkboxes — they're the practical discipline that separates research that holds up over time from research that

How to read HPLC chromatogram peptide purity peak identification step by step Durham Peptides Canada Most researchers who buy peptides have looked at an HPLC chromatogram on a Certificate of Analysis — and most have only a rough sense of what they're actually looking at. The 99% number gets the attention, but the shape of the chromatogram, the peak placements, and the pattern of impurities tell a story the number alone doesn't. This post walks through reading a chromatogram s

Peptide receptor families incretin GHS calcitonin melanocortin GHRH research map Durham Peptides Canada Every research peptide does its work by binding a receptor. That sentence sounds obvious, but it hides something important: there's no single "peptide receptor system." Different peptides engage different receptor families, with different signaling cascades, different downstream effects, and different research applications. Understanding the receptor landscape is what separ

Methionine oxidation peptide degradation chemistry stability research compound Durham Peptides Canada When researchers talk about peptide "stability," they're talking about a small set of specific chemical reactions — degradation pathways — that change a peptide's structure over time, especially when stored or handled improperly. The most important of these is oxidation of methionine residues, but it's not the only one. Understanding what's actually happening at the chemistry

How to read peptide vial label compound mass purity lot storage research compound Durham Peptides Canada A peptide vial label is small, easily ignored, and dense with information that matters. Most quality-discipline guidance in the field focuses on the COA — and rightly so, since the COA is the authoritative document — but the vial label is the physical checkpoint, the thing in your hand at the bench. A research-grade label tells you (and proves) several specific things; a s

Peptide research project lifecycle planning ordering conducting documentation cleanup Durham Peptides Canada Most peptide research guidance focuses on individual pieces — how to design a protocol, how to reconstitute, how to read a COA — without stepping back to map the whole arc. A peptide research project is a project, not a single event, and treating it as such is the difference between work that's defensible and work that's chaotic. This article walks through the full lif

Peptide blend vs separate vials decision framework combination research Durham Peptides Canada The peptide research catalog has expanded steadily toward pre-formulated blends — the Wolverine Stack, the Glow Blend, the KLOW formulation, the CJC-1295 + Ipamorelin blend, CagriSema — and that growth raises a real question for researchers planning a protocol: when does a blend actually make sense, and when are separate vials the better choice? It's not a one-size answer. Each deci

Peptide research lab notebook documentation batch COA reconstitution reproducibility Durham Peptides Canada The single most undervalued piece of research equipment isn't the centrifuge, the freezer, or the calculator — it's the lab notebook. Every research protocol depends on being able to reconstruct what was done, with which material, in what conditions, with what result. For peptide research specifically, the volume of moving parts — different batches, reconstitution volum

Amylin pathway cagrilintide CagriSema metabolic research calcitonin receptor Durham Peptides Canada The metabolic peptide research field is built around a handful of named pathways — GLP-1, GIP, glucagon, and increasingly, amylin. Of these, amylin is the least familiar to most researchers despite being one of the original hormones in the metabolic family, co-secreted with insulin by the same beta cells. Recent attention has shifted toward amylin not because the pathway is new

KPV vs BPC-157 gut research inflammatory bowel anti-inflammatory tripeptide pentadecapeptide Durham Peptides Canada KPV and BPC-157 both have substantial literatures in gut research, and that overlap leads researchers to ask the obvious comparison question: which mechanism does what, and how do they relate? It's a sharper question than most peptide-vs-peptide comparisons because both compounds were independently studied for their effects on gastrointestinal inflammation — but

KPV Lys-Pro-Val tripeptide alpha-MSH anti-inflammatory gut skin research Durham Peptides Canada KPV is one of the smallest peptides in the entire research peptide field — just three amino acids — and one of the more mechanistically distinct. Where most anti-inflammatory research peptides act through tissue-repair or immune-modulating pathways, KPV's research story traces back to a much larger molecule: it's the C-terminal fragment of α- MSH (alpha-melanocyte-stimulating hormo

GHK-Cu skin hair collagen copper peptide regeneration research Durham Peptides Canada Of all the research peptides, GHK-Cu has the deepest connection to skin and hair science — it's the copper tripeptide that launched the entire "copper peptide" category in dermatological research, backed by over 100 published studies across five decades. When researchers search for the science behind copper peptides in skin regeneration, collagen synthesis, and follicle studies, GHK-Cu is th

GLOW vs KLOW peptide blend GHK-Cu BPC-157 TB-500 KPV comparison Durham Peptides Canada "GLOW" and "KLOW" are two of the most-searched multi-peptide blend names in skin and recovery research, and they're easy to confuse — the names differ by a single letter, and they share most of the same ingredients. The difference comes down to one additional peptide. This article explains what each blend contains, how the shared base works, and how to think about the comparison from a rese

MOTS-c vs Epithalon mitochondrial telomere longevity peptide comparison Durham Peptides Canada MOTS-c and Epithalon are both longevity research peptides, both attract interest from researchers studying the biology of aging, and both turn up in "best anti-aging peptide" searches. But comparing them head-to-head reveals how little they actually overlap: they target completely different hallmarks of aging, through entirely separate mechanisms. The "vs" here isn't about which is

Peptide half-life short-acting long-acting pharmacokinetics research compounds Durham Peptides Canada Two peptides can target the very same receptor and behave completely differently in a research model — not because of what they do, but because of how long they last. Half-life, the measure of how quickly a compound is cleared, is one of the most consequential and most overlooked properties in peptide research. It shapes how a compound is studied, why certain molecules were e

How to spot underdosed counterfeit fake research peptides COA verification Durham Peptides Canada The uncomfortable reality of the research peptide market is that not every vial contains what its label claims. Underdosed material (less peptide than stated), mislabeled material (a different or cheaper compound), and outright counterfeit products all circulate — and because lyophilized powder looks identical regardless of what's actually in the vial, you cannot tell good materi